Treating solid cancers with a new strategy

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISBN: 9783936536768

Dimensions: 21 cm

Extent: 51 S.

Edition: 1. Aufl.

Language: Englisch

Notes: graph. Darst.
Literaturangaben

Keyword: Krebs
Chemotherapie
Glutaminstoffwechsel
Krebs
Onkologie

Event: Veröffentlichung

(where): Münster

(who): ImPrint

(when): 2014

Creator: Schäfer, Rainer

Table of contents: https://d-nb.info/1050001400/04

Rights: Bei diesem Objekt liegt nur das Inhaltsverzeichnis digital vor. Der Zugriff darauf ist unbeschränkt möglich.

Last update: 11.06.2025, 1:40 PM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Schäfer, Rainer
ImPrint

Time of origin

2014

Other Objects (12)

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Novel strategy for treating neural disease

Traditional Chinese medicine in treating upper digestive tract cancers

Personalized nanovaccines for treating solid cancer metastases

At the bedside: profiling and treating patients with CXCR4‐expressing cancers

The healthcare costs of treating human papillomavirus-related cancers in Norway

Roles of exosomes in immunotherapy for solid cancers

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

Shared heritability and functional enrichment across six solid cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Mitochondrial transplantation: a promising strategy for treating degenerative joint diseases

Measurable residual disease (MRD)-testing in haematological and solid cancers

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Novel strategy for treating neural disease

Traditional Chinese medicine in treating upper digestive tract cancers

Personalized nanovaccines for treating solid cancer metastases

At the bedside: profiling and treating patients with CXCR4‐expressing cancers

The healthcare costs of treating human papillomavirus-related cancers in Norway

Roles of exosomes in immunotherapy for solid cancers

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

Shared heritability and functional enrichment across six solid cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Mitochondrial transplantation: a promising strategy for treating degenerative joint diseases

Measurable residual disease (MRD)-testing in haematological and solid cancers

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Novel strategy for treating neural disease

Traditional Chinese medicine in treating upper digestive tract cancers

Personalized nanovaccines for treating solid cancer metastases

At the bedside: profiling and treating patients with CXCR4‐expressing cancers

The healthcare costs of treating human papillomavirus-related cancers in Norway

Roles of exosomes in immunotherapy for solid cancers

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

Shared heritability and functional enrichment across six solid cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Mitochondrial transplantation: a promising strategy for treating degenerative joint diseases

Measurable residual disease (MRD)-testing in haematological and solid cancers

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Treating solid cancers with a new strategy

Object Details

Classification and Topics

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Novel strategy for treating neural disease

Traditional Chinese medicine in treating upper digestive tract cancers

Personalized nanovaccines for treating solid cancer metastases

At the bedside: profiling and treating patients with CXCR4‐expressing cancers

The healthcare costs of treating human papillomavirus-related cancers in Norway

Roles of exosomes in immunotherapy for solid cancers

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

Shared heritability and functional enrichment across six solid cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Mitochondrial transplantation: a promising strategy for treating degenerative joint diseases

Measurable residual disease (MRD)-testing in haematological and solid cancers

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Novel strategy for treating neural disease

Traditional Chinese medicine in treating upper digestive tract cancers

Personalized nanovaccines for treating solid cancer metastases

At the bedside: profiling and treating patients with CXCR4‐expressing cancers

The healthcare costs of treating human papillomavirus-related cancers in Norway

Roles of exosomes in immunotherapy for solid cancers

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

Shared heritability and functional enrichment across six solid cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Mitochondrial transplantation: a promising strategy for treating degenerative joint diseases

Measurable residual disease (MRD)-testing in haematological and solid cancers

Chk1 Inhibition as a novel therapeutic strategy for treating triple-negative breast and ovarian cancers

Novel strategy for treating neural disease

Traditional Chinese medicine in treating upper digestive tract cancers

Personalized nanovaccines for treating solid cancer metastases

At the bedside: profiling and treating patients with CXCR4‐expressing cancers

The healthcare costs of treating human papillomavirus-related cancers in Norway

Roles of exosomes in immunotherapy for solid cancers

Treating ARID1A mutated cancers by harnessing synthetic lethality and DNA damage response

Shared heritability and functional enrichment across six solid cancers

Targeting CD24 as a novel immunotherapy for solid cancers

Mitochondrial transplantation: a promising strategy for treating degenerative joint diseases

Measurable residual disease (MRD)-testing in haematological and solid cancers

Related objects

Reset password